{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:56Z","timestamp":1792294496721,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.mayocp.2023.12.018","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T10:06:33Z","timestamp":1711965993000},"page":"542-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-431X","authenticated-orcid":false,"given":"Abhinav","family":"Singla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Anstine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan K.","family":"Rosedahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya B.","family":"Mohabbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Philpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.mayocp.2023.12.018_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2023.12.018_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.berh.2007.03.003","article-title":"Epidemiology of chronic musculoskeletal pain","volume":"21","author":"McBeth","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.12.018_bib3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2023.12.018_bib5","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semarthrit.2014.01.001","article-title":"Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI","volume":"44","author":"Cagnie","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl 12","key":"10.1016\/j.mayocp.2023.12.018_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.09.006","article-title":"Fibromyalgia: an overview","volume":"122","author":"Clauw","year":"2009","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2023.12.018_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.mayocp.2023.12.018_bib9","first-page":"819","article-title":"Defective endogenous pain modulation in fibromyalgia: a meta-analysis of temporal summation and conditioned pain modulation paradigms","volume":"19","author":"O'Brien","year":"2018","journal-title":"J\u00a0Pain"},{"issue":"7","key":"10.1016\/j.mayocp.2023.12.018_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/00325481.2017.1336417","article-title":"Challenges of implementing fibromyalgia treatment guidelines in current clinical practice","volume":"129","author":"Arnold","year":"2017","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2023.12.018_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrrheum.2010.120","article-title":"Pain management: fibromyalgia drugs are \u201cas good as it gets\u201d in chronic pain","volume":"6","author":"Clauw","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.mayocp.2023.12.018_bib13","first-page":"505","article-title":"Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","volume":"11","author":"Hauser","year":"2010","journal-title":"J\u00a0Pain"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"Hauser","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2023.12.018_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mayocpiqo.2019.07.003","article-title":"Use of complementary and integrative therapies by fibromyalgia patients: a 14-year follow-up study","volume":"3","author":"Mohabbat","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2023.12.018_bib16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.mayocp.2023.12.018_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3899\/jrheum.181120","article-title":"Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases","volume":"46","author":"Fitzcharles","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.mayocp.2023.12.018_bib18","first-page":"654","article-title":"Cannabis in pain treatment: clinical and research considerations","volume":"17","author":"Savage","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"17-18","key":"10.1016\/j.mayocp.2023.12.018_bib19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.phytochem.2010.10.001","article-title":"Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes","volume":"71","author":"Fischedick","year":"2010","journal-title":"Phytochemistry"},{"issue":"7","key":"10.1016\/j.mayocp.2023.12.018_bib20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.mayocp.2023.12.018_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/acm.2020.0331","article-title":"Safety and efficacy of medicinal cannabis in the treatment of fibromyalgia: a systematic review","volume":"27","author":"Kurlyandchik","year":"2021","journal-title":"J\u00a0Altern Complement Med"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/rheumatology\/keaa534","article-title":"Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis","volume":"60","author":"Guillouard","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.mayocp.2023.12.018_bib23","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/acr.24985","article-title":"Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study","volume":"75","author":"Sotoodeh","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib24","doi-asserted-by":"crossref","DOI":"10.52965\/001c.25085","article-title":"Efficacy of acupuncture in the treatment of fibromyalgia","volume":"13","author":"Berger","year":"2021","journal-title":"Orthop Rev (Pavia)"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib25","first-page":"56","article-title":"Cannabis use and its association with psychological disorders","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"7","key":"10.1016\/j.mayocp.2023.12.018_bib26","first-page":"989","article-title":"Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.mayocp.2023.12.018_bib27","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.mayocp.2018.09.005","article-title":"Medical cannabis","volume":"93","author":"Ebbert","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12875-019-0906-y","article-title":"A\u00a0survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers","volume":"20","author":"Philpot","year":"2019","journal-title":"BMC Fam Pract"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2023.12.018_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.mayocp.2023.12.018_bib31","unstructured":"National Cancer Institute Division of Cancer Control and Population Sciences. Clinical and Translational Epidemiology: Patterns of Cannabis Use Among Cancer Patients Core Measures Questionnaire. Vol 2023: National Cancer Institute Epidemiology and Genomics Research Program; 2023.(Cannabis Core Measures Questionnaire [PDF] | EGRP\/DCCPS\/NCI\/NIH (cancer.gov))"},{"key":"10.1016\/j.mayocp.2023.12.018_bib32","unstructured":"Clinical and Translational Epidemiology | EGRP\/DCCPS\/NCI\/NIH. https:\/\/epi.grants.cancer.gov\/clinical\/"},{"issue":"4","key":"10.1016\/j.mayocp.2023.12.018_bib33","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2023.12.018_bib34","first-page":"807","article-title":"Safety and efficacy of medical cannabis in fibromyalgia","volume":"8","author":"Sagy","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.mayocp.2023.12.018_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RHU.0000000000000702","article-title":"Medical cannabis for the treatment of fibromyalgia","volume":"24","author":"Habib","year":"2018","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"J\u00a0Cannabis Res"},{"issue":"Suppl 123","key":"10.1016\/j.mayocp.2023.12.018_bib37","first-page":"53","article-title":"Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study","volume":"38","author":"Giorgi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mayocp.2023.12.018_bib38","article-title":"The consumption of cannabis by fibromyalgia patients in Israel","volume":"2018","author":"Habib","year":"2018","journal-title":"Pain Res Treat"},{"issue":"13","key":"10.1016\/j.mayocp.2023.12.018_bib39","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1080\/10826084.2022.2107673","article-title":"Medical cannabis patients report improvements in health functioning and reductions in opiate use","volume":"57","author":"Pritchett","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"2","key":"10.1016\/j.mayocp.2023.12.018_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ejp.1675","article-title":"Medical cannabis treatment for chronic pain: outcomes and prediction of response","volume":"25","author":"Aviram","year":"2021","journal-title":"Eur J Pain"},{"key":"10.1016\/j.mayocp.2023.12.018_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2017.03.030","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177","author":"Childs","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.mayocp.2023.12.018_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42238-020-00024-2","article-title":"Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019)","volume":"2","author":"Cameron","year":"2020","journal-title":"J\u00a0Cannabis Res"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T02:46:02Z","timestamp":1712285162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0025619624000259"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.12.018","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}